Hims & Hers defended at BofA as Lilly fights compounded GLP-1s With Eli Lilly (NYSE:LLY) intensifying its legal efforts against compounded versions of its GLP-1 weight loss therapy, tirzepatide, Bank of…
Hims & Hers defended at BofA as Lilly fights compounded GLP-1s With Eli Lilly (NYSE:LLY) intensifying its legal efforts against compounded versions of its GLP-1 weight loss therapy, tirzepatide, Bank of…